CCL22 and neoplasm: Mature mDCs specifically expressed CCR7, CCL17 and CCL22 to recruit infiltrating T cells, which transduced immune signals and recruits peripheral T cells in TME with strong migration and regulatory capabilities, thus playing an anti-tumor role.